Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Ann Surg. 2019 May;269(5):917–923. doi: 10.1097/SLA.0000000000002450

Figure 3.

Figure 3.

(A) Lolliplots showing distribution of somatic mutations in TP53 in 263 patients undergoing resection of colorectal liver metastases. (B) Overall survival by type of TP53 mutation (n = 399). Two patients with TP53 in-frame deletions were omitted from analysis. (C) Overall survival among RAS mutated patients, by type of TP53 mutation (n = 209). EAp53, Evolutionary Action of p53; W, TP53 wild-type; T/L, truncating or EAp53 low risk mutation; H, EAp53 high risk mutation; mut, mutation.